Company Overview of North American Vaccine
As of June 2000, North American Vaccine, Inc. was acquired by Baxter International Inc. North American Vaccine, Inc., prior to the acquisition, was engaged in the research, development, manufacture, and sale of vaccines for the prevention of infectious diseases. The company had three licensed products that contained its acellular pertussis vaccine, including Certiva®, its combined diphtheria, tetanus, and acellular pertussis vaccine for infants and children, as well as 12 other products in various stages of development to prevent meningococcal, streptococcal, pneumococcal, E. coli, and HAEMOPHILUS INFLUENZAE type b infections.
10150 Old Columbia Road
Columbia, MD 21046
Key Executives for North American Vaccine
North American Vaccine does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact North American Vaccine, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.